G-INCs Lab

Nanomedicine research group in uOttawa

[G-INCs Lab @G_IncsLab]

Celebrating our CIHR grants ⁦@MCoteLab⁩. Looking forward to have great research stories coming out of our labs in next five years and more.

[G-INCs Lab @G_IncsLab]

Congrats to all authors, and this work is supported @kidneycanada @NSERC_CRSNG @CIHR_IRSC @uOttawaMed

[G-INCs Lab @G_IncsLab]

Happy to share our recent collaborative work with Prof. Kevin Burns, showing a nanotherapeutic strategy for AKI treatment. We developed NPs containing miR486-5p and showed its protective effects in vitro https://t.co/lZJGmN1ViA

[G-INCs Lab @G_IncsLab]

Acute kidney injury (AKI) can often lead to chronic kidney disease, and current treatment options are limited. Our NPs efficiently delivered miR to kidney cells and protected them against injury in in vitro models, highlighting the potential for AKI treatment.

[G-INCs Lab @G_IncsLab]

@warangal_nit @uOttawaMed @IndiaDST @NSERC_CRSNG @CIHR_IRSC

[G-INCs Lab @G_IncsLab]

Can we detect Amyloid fibrils via Photo-induced energy transfer-based fluorescent probes? https://t.co/FpFHxZEYIB

[G-INCs Lab @G_IncsLab]

In our recent collaborative work between my PhD labmate, Prof. Raghu Chitta and our PhD advisor, Francis D'Souza, we developed a water-soluble probe with excellent PEnT properties. Our preliminary work shows the detection of fibrils in CSF mimicking fluids

[uOttawa | Faculté de médecine, Faculty of Medicine @uOttawaMed]

Dr. Suresh Gadde’s G-INCs Lab is at the forefront of developing nano-sized tools for drug delivery. Now, his team has gone one step further by equipping these same delivery agents with built-in bioactivity.

💡 “Our proof-of-concept study might be the first one to show that particles can do more than just deliver and can contribute to treatment,” says Dr. Gadde, assistant professor at @uOttawaMed. “It’s more like we are arming them.”

🧬Such a concept could have significant implications for drug development, including leading to more targeted, personalized treatments for complex illnesses such as cancer and cardiovascular diseases.

Learn more 👉https://t.co/C4MYqAPZPf

@uottawa #Nanomedicine #Nanomedecine #Innovation #MedicalResearch #RechercheMedicale

[G-INCs Lab @G_IncsLab]

This work is led by our talented postdoc Shireesha. @uOttawaMed @NRC_CNRC @NSERC_CRSNG @OttawaCmm @OISB_IBSO @uOttawaCI3

[G-INCs Lab @G_IncsLab]

Since millions of particles are injected to deliver each dose, we thought it would be good if they could do more than deliver the therapeutic agents. https://t.co/ZKeV2pb6vo

[Ottawa Art Gallery | Galerie d'art d'Ottawa @OttawaArtG]

Congratulations to Simon Brascoupe, OAG Special Advisor, on receiving an honorary doctorate from @uOttawa!

[ACS Publications @ACSPublications]

Nanoparticles are advancing DNA and RNA therapeutics, improving stability and efficiency. With our upcoming journal, ACS Nano Medicine, researchers have a new home for their groundbreaking discoveries.

🔗 Read our curated Collection 👉 https://t.co/ql1P6sXWcg

[UNT Department of Chemistry @UNTChemistry]

We're proud of our two @UNTChemistry colleagues who received major awards at the 2025 UNT Salute to Faculty Excellence: Francis D'Souza - Eminent Faculty Award, and @shengqianma - University Distinguished Research Professor

[uOttawa | Faculté de médecine, Faculty of Medicine @uOttawaMed]

Congratulations to Dr. Kevin Burns, professor at @uOttawaMed, has been awarded the #KingCharlesIIICoronation Medal in recognition of his exemplary contributions in the field of nephrology and kidney research. 👏

🔗 https://t.co/E16zsEu6Rk

@GGCanada

[NIT Warangal @warangal_nit]

The Department of Chemistry of National Institute of Technology Warangal has inaugurated a 8-day workshop on “Nanotheranostics: From Basic Principles to Clinical Utility” .Prof. Suresh Gadde, University of Ottawa, Canada in the domain of nanomedicine is the expert speaker.
#nitw

[OISB @OISB_IBSO]

New from @G_IncsLab at @OISB_IBSO:

https://t.co/FISQdBDBqI

[uOttawa | Faculté de médecine, Faculty of Medicine @uOttawaMed]

🌟 Des recherches révolutionnaires co-dirigées par le Dr Suresh Gadde de @uOttawaMed montrent que la combinaison des thérapies à base d’#ARNmessager et d’#interférenceARN pourrait transformer les traitements contre le #Cancer et les #MaladiesCardiovasculaires ! 🧬

En savoir plus : https://t.co/OIoZQPvcaS

@SuriSpurs @OttawaCmm @uOttawa @uOttawaResearch  #ResearchResearch

[G-INCs Lab @G_IncsLab]

This work is co-led by our talented trainees, Shireesha and Sara. @uOttawaMed @uOttawaBMI @OttawaCmm @MCoteLab @NRC_CNRC @OISB_IBSO @uOttawaCI3 @CIHR_IRSC

[G-INCs Lab @G_IncsLab]

Can we differentially manipulate multiple gene/protein expressions? In this collaborative work Dr. Wang, we showed simultaneous restoration and silencing of two different Gene/Protein expressions in vivo in TNBC models using NPs containing mRNA and siRNA
https://t.co/JbzG6ZuBkX

[G-INCs Lab @G_IncsLab]

Thanks a lot for visiting us.

[Emmanuel Ho @HoResearchGroup]

Thank you once again Prof Gadde for the invitation to share some of the research happening in the #HoResearchGroup. It was also a pleasure to chat with the trainees and researchers at University of Ottawa Faculty of Medicine and to learn about all the ground-breaking research!

[Emmanuel Ho @HoResearchGroup]

Looking forward to visiting @uOttawaMed to share some of the research happening in our group. Thank you @SuriSpurs @G_IncsLab for the invitation!